Another CBD Suit Put On Hold While FDA Develops Rules

Law360 (June 16, 2020, 10:10 PM EDT) -- A California federal judge has hit pause on a proposed class action alleging a Florida CBD company mislabeled its products, saying the suit can wait until the U.S. Food and Drug Administration releases long-awaited rules regulating the popular hemp-derived compound.

Monday's decision marks at least the third time this year a federal judge has stayed a consumer class action against a CBD company, pending anticipated FDA rulemaking, while citing the doctrine of primary jurisdiction, under which courts can defer matters where a regulator has primary oversight.

Following the analysis of similar decisions this year in California and Florida federal court, U.S....

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Beta
Ask a question!